The CRISPR Medicine That Cured a Child: How Yuri Milner’s Breakthrough Prize Brought Gene Therapy to Hollywood
The Breakthrough Prize ceremony celebrated a child cured of a genetic disease using gene editing therapy, highlighting the work of scientists who received $3 million prizes. The therapy, Casgevy, was made possible by decades of research into hemoglobin and the development of CRISPR gene editing.
Scientists Stuart H. Orkin and Swee Lay Thein were honored at the Breakthrough Prize ceremony for their work on gene editing therapy. Their research identified the BCL11A gene as a key player in fetal hemoglobin suppression and showed that disabling it could reactivate fetal hemoglobin in adult cells. This discovery led to the development of Casgevy, the first FDA-approved gene-editing medicine for sickle cell disease and beta-thalassemia. Casgevy represents a breakthrough in treating genetic diseases at their source, rather than just managing symptoms. The therapy was celebrated onstage at the ceremony, where a child known as Baby KJ was honored for being cured of a genetic disease using the treatment. The Breakthrough Prize was established by Yuri Milner, Sergey Brin, and Mark Zuckerberg and Priscilla Chan.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.